Bivalent inhibition of human beta-tryptase

Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L (2001)
CHEMISTRY & BIOLOGY 8(4): 313-327.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
CHEMISTRY & BIOLOGY
Band
8
Zeitschriftennummer
4
Seite
313-327
ISSN
PUB-ID

Zitieren

Schaschke N, Matschiner G, Zettl F, et al. Bivalent inhibition of human beta-tryptase. CHEMISTRY & BIOLOGY. 2001;8(4):313-327.
Schaschke, N., Matschiner, G., Zettl, F., Marquardt, U., Bergner, A., Bode, W., Sommerhoff, C. P., et al. (2001). Bivalent inhibition of human beta-tryptase. CHEMISTRY & BIOLOGY, 8(4), 313-327. doi:10.1016/S1074-5521(01)00011-4
Schaschke, N., Matschiner, G., Zettl, F., Marquardt, U., Bergner, A., Bode, W., Sommerhoff, C. P., and Moroder, L. (2001). Bivalent inhibition of human beta-tryptase. CHEMISTRY & BIOLOGY 8, 313-327.
Schaschke, N., et al., 2001. Bivalent inhibition of human beta-tryptase. CHEMISTRY & BIOLOGY, 8(4), p 313-327.
N. Schaschke, et al., “Bivalent inhibition of human beta-tryptase”, CHEMISTRY & BIOLOGY, vol. 8, 2001, pp. 313-327.
Schaschke, N., Matschiner, G., Zettl, F., Marquardt, U., Bergner, A., Bode, W., Sommerhoff, C.P., Moroder, L.: Bivalent inhibition of human beta-tryptase. CHEMISTRY & BIOLOGY. 8, 313-327 (2001).
Schaschke, Norbert, Matschiner, G, Zettl, F, Marquardt, U, Bergner, A, Bode, W, Sommerhoff, CP, and Moroder, L. “Bivalent inhibition of human beta-tryptase”. CHEMISTRY & BIOLOGY 8.4 (2001): 313-327.

25 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Iminosugar-Cyclopeptoid Conjugates Raise Multivalent Effect in Glycosidase Inhibition at Unprecedented High Levels.
Lepage ML, Schneider JP, Bodlenner A, Meli A, De Riccardis F, Schmitt M, Tarnus C, Nguyen-Huynh NT, Francois YN, Leize-Wagner E, Birck C, Cousido-Siah A, Podjarny A, Izzo I, Compain P., Chemistry 22(15), 2016
PMID: 26917097
Emerging trends in enzyme inhibition by multivalent nanoconstructs.
Kanfar N, Bartolami E, Zelli R, Marra A, Winum JY, Ulrich S, Dumy P., Org Biomol Chem 13(39), 2015
PMID: 26338715
A new approach to inhibit human β-tryptase by protein surface binding of four-armed peptide ligands with two different sets of arms.
Jiang QQ, Bartsch L, Sicking W, Wich PR, Heider D, Hoffmann D, Schmuck C., Org Biomol Chem 11(10), 2013
PMID: 23358683
Tryptogalinin is a tick Kunitz serine protease inhibitor with a unique intrinsic disorder.
Valdés JJ, Schwarz A, Cabeza de Vaca I, Calvo E, Pedra JH, Guallar V, Kotsyfakis M., PLoS One 8(5), 2013
PMID: 23658744
Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
Sommerhoff CP, Avrutina O, Schmoldt HU, Gabrijelcic-Geiger D, Diederichsen U, Kolmar H., J Mol Biol 395(1), 2010
PMID: 19852971
Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities.
Liu SP, Zhou L, Lakshminarayanan R, Beuerman RW., Int J Pept Res Ther 16(3), 2010
PMID: 20835389
Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells.
Palmer HS, Kelso EB, Lockhart JC, Sommerhoff CP, Plevin R, Goh FG, Ferrell WR., Arthritis Rheum 56(11), 2007
PMID: 17968878
X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition.
Rohr KB, Selwood T, Marquardt U, Huber R, Schechter NM, Bode W, Than ME., J Mol Biol 357(1), 2006
PMID: 16414069
Biology of mast cell tryptase. An inflammatory mediator.
Hallgren J, Pejler G., FEBS J 273(9), 2006
PMID: 16640553
Romping the cellular landscape: linear scaffolds for molecular recognition.
Lee Y, Sampson NS., Curr Opin Struct Biol 16(4), 2006
PMID: 16781140
Affinity chromatography of tryptases: design, synthesis and characterization of a novel matrix-bound bivalent inhibitor.
Schaschke N, Gabrijelcic-Geiger D, Dominik A, Sommerhoff CP., Chembiochem 6(1), 2005
PMID: 15593113
Carbohydrates in peptide and protein design.
Jensen KJ, Brask J., Biopolymers 80(6), 2005
PMID: 15929028
Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human beta-tryptase.
Vaz RJ, Gao Z, Pribish J, Chen X, Levell J, Davis L, Albert E, Brollo M, Ugolini A, Cramer DM, Cairns J, Sides K, Liu F, Kwong J, Kang J, Rebello S, Elliot M, Lim H, Chellaraj V, Singleton RW, Li Y., Bioorg Med Chem Lett 14(24), 2004
PMID: 15546728
Hitting multiple targets with multimeric ligands.
Handl HL, Vagner J, Han H, Mash E, Hruby VJ, Gillies RJ., Expert Opin Ther Targets 8(6), 2004
PMID: 15584863
Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
Selwood T, Elrod KC, Schechter NM., Biol Chem 384(12), 2003
PMID: 14719803
Bivalent inhibition of beta-tryptase: distance scan of neighboring subunits by dibasic inhibitors.
Schaschke N, Dominik A, Matschiner G, Sommerhoff CP., Bioorg Med Chem Lett 12(6), 2002
PMID: 11959009
The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region.
Marquardt U, Zettl F, Huber R, Bode W, Sommerhoff C., J Mol Biol 321(3), 2002
PMID: 12162961

59 References

Daten bereitgestellt von Europe PubMed Central.

Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse.
Hunt JE, Stevens RL, Austen KF, Zhang J, Xia Z, Ghildyal N., J. Biol. Chem. 271(5), 1996
PMID: 8576265
Inhibition of human mast cell tryptase by benzamidine derivatives.
Sturzebecher J, Prasa D, Sommerhoff CP., Biol. Chem. Hoppe-Seyler 373(10), 1992
PMID: 1418674
Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH, Raymond WW, Bacci E, Lombardy RJ, Tidwell RR., J. Pharmacol. Exp. Ther. 264(2), 1993
PMID: 8437115
Potent selective nonpeptidic inhibitors of human lung tryptase.
Burgess LE, Newhouse BJ, Ibrahim P, Rizzi J, Kashem MA, Hartman A, Brandhuber BJ, Wright CD, Thomson DS, Vigers GP, Koch K., Proc. Natl. Acad. Sci. U.S.A. 96(15), 1999
PMID: 10411878
Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors.
Ono S, Kuwahara S, Takeuchi M, Sakashita H, Naito Y, Kondo T., Bioorg. Med. Chem. Lett. 9(23), 1999
PMID: 10612586
Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
Rice KD, Gangloff AR, Kuo EY, Dener JM, Wang VR, Lum R, Newcomb WS, Havel C, Putnam D, Cregar L, Wong M, Warne RL., Bioorg. Med. Chem. Lett. 10(20), 2000
PMID: 11055355
Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
Rice KD, Wang VR, Gangloff AR, Kuo EY, Dener JM, Newcomb WS, Young WB, Putnam D, Cregar L, Wong M, Simpson PJ., Bioorg. Med. Chem. Lett. 10(20), 2000
PMID: 11055356
A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.
Sommerhoff CP, Sollner C, Mentele R, Piechottka GP, Auerswald EA, Fritz H., Biol. Chem. Hoppe-Seyler 375(10), 1994
PMID: 7888081

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 11325588
PubMed | Europe PMC

Suchen in

Google Scholar